Movement Disorders Clinical Trials
Researchers at NYU Langone’s Fresco Institute for Parkinson’s and Movement Disorders conduct clinical trials to advance the understanding and treatment of Parkinson’s disease and movement disorders.
For more information about research at the Fresco Institute, call our research team at 646-501-4367 or email pdresearch@NYULangone.org.
Mechanisms of Parkinson’s Disease and Associated Disorders
GBA1 Mutations and Parkinson’s Disease
Principal Investigator: Giulietta M. Riboldi, MD, PhD
The New York Movement Disorder (NYMD) Study
Principal Investigator: Steven J. Frucht, MD
Movement Disorders Genomic Study
Principal Investigator: Giulietta M. Riboldi, MD, PhD
Parkinson's Foundation PD GENEration Genetic Registry
Site-Principal Investigator: Giulietta M. Riboldi, MD, PhD
Therapeutic Trials in Parkinson’s Disease and Other Movement Disorders
Un J. Kang, MD, is on the steering committee of a multicenter NIH-funded exercise trial for Parkinson’s disease (SPARX3) and leads the biomarker core to discover biological changes that occur with exercise. The SPARX3 website lists sites that enroll patients for the study.
Observational and Biomarker Studies in Parkinson’s Disease
The Parkinson’s Progression Markers Initiative (PPMI) 2.0 Clinical — Establishing a Deeply Phenotyped PD Cohort
Site-Principal Investigator: Giulietta M. Riboldi, MD, PhD
Epigenetic Characterization of Immune Cells in Parkinson’s disease and Prodromal Stages (EpiGEN PD) Study
Principal Investigator: Giulietta M. Riboldi, MD, PhD
Genetic Screening Outcomes in Movement Disorders
Principal Investigator: Giulietta M. Riboldi, MD, PhD
Young Onset Parkinson’s disease Subtypes and Pathogenic Mechanisms (YOPD) Study
Principal Investigator: Giulietta M. Riboldi, MD, PhD
Prodromal and Early Parkinsonism Alpha-Synuclein Study
Principal Investigator: Un J. Kang, MD
A Single Center, Observational Study, for the Characterization of Eye Movement Abnormalities Patients with Movement Disorders Using the NeuroCluesTM Technology (NeuroClues Study)
Principal Investigator: Steven Frucht, MD